Illuminating luminal B: QSOX1 as a subtype-specific biomarker

Summary

Quiescin sulfhydryl oxidase 1 (QSOX1) is linked to poor prognosis in luminal B breast cancer. This enzyme promotes cancer growth and spread, suggesting it could be a therapeutic target and biomarker for this subtype.